[go: up one dir, main page]

DE69522104D1 - Tränendrüsen spezifische emulsion zur topischen anwendung an okulären geweben - Google Patents

Tränendrüsen spezifische emulsion zur topischen anwendung an okulären geweben

Info

Publication number
DE69522104D1
DE69522104D1 DE69522104T DE69522104T DE69522104D1 DE 69522104 D1 DE69522104 D1 DE 69522104D1 DE 69522104 T DE69522104 T DE 69522104T DE 69522104 T DE69522104 T DE 69522104T DE 69522104 D1 DE69522104 D1 DE 69522104D1
Authority
DE
Germany
Prior art keywords
tearrouses
topical application
ocular tissues
specific emulsion
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69522104T
Other languages
English (en)
Other versions
DE69522104T2 (de
Inventor
Shulin Ding
L Tien
Orest Olejnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Sales LLC
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69522104(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Publication of DE69522104D1 publication Critical patent/DE69522104D1/de
Application granted granted Critical
Publication of DE69522104T2 publication Critical patent/DE69522104T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69522104T 1994-05-17 1995-05-17 Tränendrüsen spezifische emulsion zur topischen anwendung an okulären geweben Expired - Lifetime DE69522104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/243,279 US5474979A (en) 1994-05-17 1994-05-17 Nonirritating emulsions for sensitive tissue
PCT/US1995/006302 WO1995031211A1 (en) 1994-05-17 1995-05-17 Lacrimal gland specific emulsions for topical application to ocular tissue

Publications (2)

Publication Number Publication Date
DE69522104D1 true DE69522104D1 (de) 2001-09-13
DE69522104T2 DE69522104T2 (de) 2002-04-25

Family

ID=22918100

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69529932T Expired - Lifetime DE69529932T2 (de) 1994-05-17 1995-05-17 Tränendrüsenspezifische Emulsionen zur topischen Anwendung an okuläre Gewebe
DE69522104T Expired - Lifetime DE69522104T2 (de) 1994-05-17 1995-05-17 Tränendrüsen spezifische emulsion zur topischen anwendung an okulären geweben

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69529932T Expired - Lifetime DE69529932T2 (de) 1994-05-17 1995-05-17 Tränendrüsenspezifische Emulsionen zur topischen Anwendung an okuläre Gewebe

Country Status (16)

Country Link
US (1) US5474979A (de)
EP (2) EP0759773B1 (de)
JP (2) JP3441462B2 (de)
KR (2) KR100368181B1 (de)
CN (2) CN1229136C (de)
AT (2) ATE203911T1 (de)
AU (1) AU693213B2 (de)
BR (1) BR9507664A (de)
CA (1) CA2190485C (de)
DE (2) DE69529932T2 (de)
DK (2) DK0759773T3 (de)
ES (2) ES2161895T3 (de)
GR (1) GR3036945T3 (de)
NZ (1) NZ287635A (de)
PT (2) PT1044678E (de)
WO (1) WO1995031211A1 (de)

Families Citing this family (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585104A (en) * 1995-04-12 1996-12-17 The Procter & Gamble Company Cleansing emulsions
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
JPH10218760A (ja) * 1997-02-04 1998-08-18 Nobel Igaku Kenkyusho:Kk ドライアイ治療用の微量油添加目薬
US5981607A (en) * 1998-01-20 1999-11-09 Allergan Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
AUPQ228199A0 (en) * 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
ATE402925T2 (de) * 1999-10-15 2008-08-15 Sucampo Ag Neue zusammensetzung enthaltend eine bicyclische verbindung und ein glycerid
US7270767B1 (en) 1999-10-18 2007-09-18 Foster-Miller, Inc. Environmentally friendly de-icer and anti-icer compositions
ATE250924T1 (de) * 2000-04-07 2003-10-15 Medidom Lab Cyklosporin, hyaluronsäure und polysorbate enthaltenes augenarzneimittel
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
PT2153819E (pt) 2000-07-14 2012-11-14 Allergan Inc Utilização de um componente para aumento de solubilidade numa composição aquosa compreendendo tartarato de brimonidina
US7112588B2 (en) 2001-05-21 2006-09-26 Alcon, Inc. Use of proteasome inhibitors to treat dry eye disorders
MXPA03010634A (es) 2001-05-21 2004-03-09 Alcon Inc Uso de inhibidores de proteasoma para tratar trastornos del ojo seco.
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
WO2002095704A1 (en) 2001-05-21 2002-11-28 Alcon, Inc. Use of nf-kappa-b inhibitors to treat dry eye disorders
US6645994B1 (en) 2001-06-01 2003-11-11 Alcon, Inc. Method of treating dry eye disorders
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
BR0213661A (pt) * 2001-10-19 2004-10-26 Isotechnika Inc Pré-concentrado de microemulsão e método para seu preparo, formulação farmacêutica e método para seu preparo, método para produzir imuno, supressão, método para aumentar os efeitos imuno supressores de isatx247, uso de formulação farmacêutica
US6656460B2 (en) 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
US6984628B2 (en) 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
US20060009522A1 (en) 2004-07-01 2006-01-12 Reza Dana Compositions and methods for treating eye disorders and conditions
KR100875042B1 (ko) 2004-07-01 2008-12-19 이-엘 매니지먼트 코포레이션 화장용 조성물 및 감각기관의 청량감 발생 방법
US7151085B2 (en) 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
WO2010102078A1 (en) 2009-03-04 2010-09-10 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
CN100478025C (zh) * 2005-03-25 2009-04-15 中国科学院上海药物研究所 一种环孢菌素a眼用微乳制剂及其制备方法
CN100562340C (zh) * 2005-06-17 2009-11-25 中国科学院上海药物研究所 一种微乳型人工泪液
CN1319515C (zh) * 2005-07-12 2007-06-06 沈阳何氏生物工程有限公司 活肤眼霜
US7276476B2 (en) 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
US11311477B2 (en) 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
US9561178B2 (en) * 2006-07-25 2017-02-07 Allergan, Inc. Cyclosporin compositions
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US20100144609A1 (en) * 2007-05-04 2010-06-10 Donnenfeld Eric D Methods using cyclosporin in treating patients with intraocular lenses
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
EP2197461B1 (de) 2007-10-08 2018-02-21 Aurinia Pharmaceuticals Inc. Ophthalmische zusammensetzungen mit calcineurin-hemmern oder mtor-hemmern
KR100985279B1 (ko) * 2008-03-05 2010-11-05 디렉스 팜 (주) 안구건조증 치료를 위한 안약조성물 및 그 제조방법
JP5661035B2 (ja) * 2008-07-10 2015-01-28 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 眼および皮膚の疾患および症状の治療用のシクロスポリン誘導体
US20100016219A1 (en) * 2008-07-19 2010-01-21 Jerry Zhang Ophthalmic compositions containing solubilized cyclosporin
FR2938757B1 (fr) * 2008-11-27 2010-12-31 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
EA201190089A1 (ru) * 2009-01-08 2012-02-28 Аллерган, Инк. Композиции для усиления роста ногтей
US20110009339A1 (en) 2009-04-14 2011-01-13 Allergan, Inc Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
WO2010127301A1 (en) * 2009-05-01 2010-11-04 Allergan, Inc. Method of treating allergic conjunctivitis with cyclosporin compositions
ES2646338T3 (es) 2009-06-05 2017-12-13 Allergan, Inc. Lágrimas artificiales y usos terapéuticos
EP2440185B1 (de) 2009-06-09 2015-04-08 Aurinia Pharmaceuticals Inc. Topische arzneimittelabgabesysteme zur ophthalmischen verwendung
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
MX361709B (es) 2009-11-09 2018-12-07 Allergan Inc Composiciones y metodos para estimular el crecimiento del cabello.
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
CN101897949B (zh) * 2010-02-24 2016-07-06 温士顿医药股份有限公司 低刺激性透明乳化液剂型以供眼睛或眼睛周围有关组织表面免疫调节及消炎的眼用药物组合物
WO2011150102A1 (en) * 2010-05-25 2011-12-01 Allergan, Inc. Cyclosporin emulsions
WO2012015211A2 (ko) * 2010-07-30 2012-02-02 주식회사종근당 사이클로스포린 에이 함유 점안제 조성물
US8492422B2 (en) 2010-09-16 2013-07-23 Allergan, Inc. Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
WO2012051194A1 (en) 2010-10-12 2012-04-19 Allergan, Inc. Cyclosporin analogs
BR112013008749A2 (pt) 2010-10-12 2019-09-24 Allergan Inc análogos de ciclosporina
JP6042343B2 (ja) 2010-11-18 2016-12-14 スティーヴン ヨーリン 毛髪成長のための組成物及び方法
US9018202B2 (en) 2010-12-03 2015-04-28 Allergan, Inc. Methods for treating diseases of the retina
CN103282044B (zh) * 2010-12-28 2016-07-06 韩林制药株式会社 纳米乳剂形态的眼科用组合物
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
BR112013019257B1 (pt) 2011-01-26 2019-09-03 Allergan Inc composição de androgênio para tratar uma condição oftálmica
US9610245B2 (en) 2011-03-14 2017-04-04 Drug Delivery Solutions Limited Ophthalmic composition
EP3521302A1 (de) 2011-05-27 2019-08-07 Allergan, Inc. Neue kristalline form von cyclosporin a, verfahren zur herstellung und verfahren zur verwendung davon
RU2014102492A (ru) * 2011-06-29 2015-08-10 Аллерган, Инк. Композиции макрогол 15 гидроксистеарата
US20130029919A1 (en) 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery
DE102011108948A1 (de) 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP2014528447A (ja) 2011-10-05 2014-10-27 アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 爪の健康状態を増進するための組成物
RU2014117580A (ru) * 2011-10-05 2015-11-10 Аллерган, Инк. Составы для улучшения здоровья ногтей
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US8796222B2 (en) 2011-11-15 2014-08-05 Allergan, Inc. Suspensions of cyclosporin A form 2
US20130123194A1 (en) * 2011-11-15 2013-05-16 Allergan, Inc. Autoclavable suspensions of cyclosporin a form 2
US9095576B2 (en) 2011-11-21 2015-08-04 Allergan, Inc. Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
WO2013116186A1 (en) 2012-01-30 2013-08-08 Allergan, Inc. Brimonidine for treating visual disorders mediated by central visual projections from the eye
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
US20150164765A1 (en) 2012-05-17 2015-06-18 Steven G. Yoelin Compositions and methods for hair growth
AU2013267435B2 (en) 2012-06-01 2017-11-09 Allergan, Inc. Cyclosporin A analogs
WO2014138437A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Steroid conjugates
KR101492447B1 (ko) 2013-05-20 2015-02-23 주식회사태준제약 사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법
MX384947B (es) * 2014-07-18 2025-03-14 Allergan Inc Composiciones en suspension de ciclosporina a para inyecciones subconjuntivales y perioculares.
MX372988B (es) 2014-11-25 2020-04-06 Allergan Inc Composiciones oftalmicas estabilizadas de omega 3.
TW201639873A (zh) 2015-01-08 2016-11-16 歐樂根公司 Ｍｅｂｍｔ側鏈已環化之環孢菌素衍生物
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
BR112017016645A2 (pt) 2015-02-06 2019-09-24 Scherer Technologies Llc R P preparação de uma emulsão de óleo em água para formulações farmacêuticas estabilizadas com polímero
US10077289B2 (en) 2015-03-31 2018-09-18 Allergan, Inc. Cyclosporins modified on the MeBmt sidechain by heterocyclic rings
KR101587385B1 (ko) 2015-07-29 2016-01-21 국제약품공업주식회사 사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
FR3041883B1 (fr) * 2015-10-02 2019-03-15 Chu Clermont-Ferrand Procede de preparation d'un collyre de ciclosporine a
WO2017066429A1 (en) 2015-10-14 2017-04-20 Paul Gavaris Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
CN106692052B (zh) * 2015-11-13 2021-03-26 天津金耀集团有限公司 一种环孢素眼用乳剂组合物
CN109963556A (zh) * 2016-11-17 2019-07-02 千寿制药株式会社 乳剂滴眼液
KR102115158B1 (ko) 2016-11-29 2020-05-26 주식회사 지트리파마슈티컬 티모신 베타 4 를 함유하는 제형
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
USD841152S1 (en) 2017-06-27 2019-02-19 Monica S. Naylor Eye drop container
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
CN109010268B (zh) * 2018-09-28 2020-07-10 湖北远大天天明制药有限公司 一种提高氯霉素稳定性的眼用组合物及其制备方法
EP3982930A1 (de) 2019-06-11 2022-04-20 SIFI S.p.A. Mikroemulsionszusammensetzungen
WO2021008668A1 (en) * 2019-07-12 2021-01-21 Pharmathen S.A. Preservative free pharmaceutical composition for ophthalmic administration containing cyclosporine
IL319105A (en) 2019-08-07 2025-04-01 Aneira Pharma Inc Hair loss treatment products
GR1010012B (el) * 2020-05-12 2021-05-27 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον κυκλοσπορινη
CN113749092B (zh) * 2020-06-03 2024-10-11 迈克斯(如东)化工有限公司 不饱和脂肪酸酯化物应用、农化组合物和低眼刺农药制剂及其应用
IL294896A (en) * 2022-07-20 2024-02-01 LYOTROPIC DELIVERY SYSTEMS Ltd Topical administration of cyclosporine to the eye
WO2024150216A1 (en) * 2023-01-09 2024-07-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Topical compositions and methods for treating alopecia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH204625A (de) * 1937-07-13 1939-05-15 Telefunken Gmbh Eisenkernspule mit als Drehkondensator ausgebildetem Abgleichkondensator.
US2224205A (en) * 1938-07-18 1940-12-10 Hoover Co Suction cleaner
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS59196816A (ja) * 1983-04-22 1984-11-08 Senjiyu Seiyaku Kk 水溶性アズレン誘導体の安定な水溶液の製造法
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
ATE109970T1 (de) * 1987-09-03 1994-09-15 Univ Georgia Res Found Cyclosporin-augenmittel.
CA1326995C (en) * 1988-01-29 1994-02-15 Kozo Kurihara Cyclosporin compositions
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5364632A (en) * 1989-04-05 1994-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CA2052950A1 (en) * 1990-10-10 1992-04-11 David P. Evitts Aqueous ophthalmic microemulsions of tepoxalin
JPH0558906A (ja) * 1991-09-06 1993-03-09 Sankyo Co Ltd シクロスポリン点眼製剤
JPH06219949A (ja) * 1993-01-25 1994-08-09 Mitsubishi Kasei Corp 抗トロンビン剤及びその製造方法

Also Published As

Publication number Publication date
NZ287635A (en) 1998-09-24
JP2003231646A (ja) 2003-08-19
EP0759773B1 (de) 2001-08-08
DE69529932D1 (de) 2003-04-17
CN1288722A (zh) 2001-03-28
BR9507664A (pt) 1997-10-07
JP4119284B2 (ja) 2008-07-16
ES2161895T3 (es) 2001-12-16
US5474979A (en) 1995-12-12
GR3036945T3 (en) 2002-01-31
JPH10500414A (ja) 1998-01-13
AU2640995A (en) 1995-12-05
EP1044678B1 (de) 2003-03-12
DK1044678T3 (da) 2003-07-14
KR100368181B1 (ko) 2003-04-10
CA2190485C (en) 2003-04-15
HK1034190A1 (en) 2001-10-19
CN1152876A (zh) 1997-06-25
MX9605599A (es) 1998-08-30
ATE234076T1 (de) 2003-03-15
DE69522104T2 (de) 2002-04-25
DE69529932T2 (de) 2003-12-18
KR100450703B1 (ko) 2004-10-01
ES2194670T3 (es) 2003-12-01
ATE203911T1 (de) 2001-08-15
CN1198587C (zh) 2005-04-27
PT1044678E (pt) 2003-08-29
JP3441462B2 (ja) 2003-09-02
AU693213B2 (en) 1998-06-25
EP1044678A1 (de) 2000-10-18
DK0759773T3 (da) 2001-11-26
WO1995031211A1 (en) 1995-11-23
CN1229136C (zh) 2005-11-30
PT759773E (pt) 2002-02-28
EP0759773A1 (de) 1997-03-05
CA2190485A1 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
DE69522104D1 (de) Tränendrüsen spezifische emulsion zur topischen anwendung an okulären geweben
CA2159606A1 (en) Skin care composition containing emulsified petroleum jelly
DE69515369D1 (de) Tensidefreie Wasser-in-Öl Emulsion
FR2756176B1 (fr) Composition cosmetique comprenant un compose fluore et presentant un confort ameliore
ATE132366T1 (de) Zusammensetzung zur behandlung von dry eye erkrankungen
DE50013111D1 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
WO1996007396A3 (en) Retinoid compositions
ES2033626T1 (es) Formulacion adyuvante que comprende una emulsion de gotitas de aceite submicroscopicas.
ATE326941T1 (de) Kosmetische und dermatologische zubereitungen auf der grundlage von o/w-emulsionen
DE69519496D1 (de) Zusammensetzungen, welche ein RAR alpha spezifischer Liganden und mindestens eine Fettsäure enthalten
FR2702391B1 (fr) Nouvelles émulsions multiples, leur préparation, leur application à la préparation de compositions cosmétiques et ces compositions cosmétiques.
PL304928A1 (en) Cosmetic or dermatological composition in the form of oil-in-water emulsion consisting of minute oil droplets surrounded by lamellar crystal casing and method of obtaining same
FR2725366B1 (fr) Composition cosmetique comprenant des huiles siliconees
ATE141780T1 (de) Öl in wasser emulsionen verwendbar für die herstellung von einer creme
WO2003053329A3 (fr) Composition pour la teinture d'oxydation des fibres keratiniques comprenant un amide d'acide gras de colza oxyethylene
DE69815549D1 (de) Pestizide zusammensetzung
EP1072247A3 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
AU4128901A (en) Colored visco-elastic composition
ATE219353T1 (de) O/w-emulsion enthaltende fibern und ihre verwendung in der kosmetik
AU6614798A (en) Cosmetic Phase-Inversion Temperature Emulsions
ATE319307T1 (de) Neue pestizide öl-in-wasser emulsionszusammensetzungen
DE69418892D1 (de) Selbstemulgierende formulierung zur bildung einer öl-in-wasser-emulsion
DK1395238T3 (da) Hudpræparat
DE69320638D1 (de) Topisches mittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition